Lung Cancer
Volume 70, Issue 1 , Pages 77-81 , October 2010

Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial

  • Jaeheon Jeong

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Center for Clinical Trials, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea
    • ,
  • Byoung Chul Cho

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Joo Hyuk Sohn

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Hye Jin Choi

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Se Hyun Kim

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Young Joo Lee

      Affiliations

    • Center for Clinical Trials, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea
    • ,
  • Min Kyu Jung

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Sang Joon Shin

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Moo-Suk Park

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Se Kyu Kim

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Joon Chang

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • Joo Hang Kim

      Affiliations

    • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Corresponding Author InformationCorresponding author at: Yonsei Cancer Center, Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-Ku, CPO Box 8044, 120-752 Seoul, Republic of Korea. Tel.: +82 2 2228 8131; fax: +82 2 392 1508.

Received 25 August 2009 ,Revised 5 January 2010 ,Accepted 7 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(10)00008-5

doi: 10.1016/j.lungcan.2010.01.006

Lung Cancer
Volume 70, Issue 1 , Pages 77-81 , October 2010

Article Tools

* Image Usage & Resolution